TMCC1-DT
gene geneOn this page
Summary
TMCC1-DT (TMCC1 divergent transcript, HGNC:49060) is a long non-coding RNA gene on chromosome 3q22.1.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:49060 |
| Approved symbol | TMCC1-DT |
| Name | TMCC1 divergent transcript |
| Location | 3q22.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000271270 |
| Ensembl biotype | lncRNA |
| Entrez | 100507032 |
| RNAcentral | URS000075B198 — lncRNA, 3497 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 14 lncRNA
ENST00000603884, ENST00000604747, ENST00000605698, ENST00000605830, ENST00000653304, ENST00000671446, ENST00000686063, ENST00000690344, ENST00000840963, ENST00000840964, ENST00000840965, ENST00000840966, ENST00000840967, ENST00000840968
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000603884 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003480416 | 129893871 | 129893927 |
| ENSE00003539201 | 129901707 | 129902205 |
Expression profiles
Bgee: expression breadth ubiquitous, 136 present calls, max score 89.24.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.5375 / max 49.0305, expressed in 1345 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 38567 | 3.5375 | 1345 |
Top tissues by expression
138 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| thymus | UBERON:0002370 | 89.24 | gold quality |
| quadriceps femoris | UBERON:0001377 | 87.82 | gold quality |
| cerebellar vermis | UBERON:0004720 | 87.10 | gold quality |
| sural nerve | UBERON:0015488 | 77.36 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.89 | gold quality |
| endometrium | UBERON:0001295 | 75.54 | gold quality |
| colonic epithelium | UBERON:0000397 | 75.34 | gold quality |
| right uterine tube | UBERON:0001302 | 74.94 | gold quality |
| ventricular zone | UBERON:0003053 | 74.85 | gold quality |
| ganglionic eminence | UBERON:0004023 | 72.54 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 71.55 | gold quality |
| cortical plate | UBERON:0005343 | 71.12 | gold quality |
| right ovary | UBERON:0002118 | 70.95 | gold quality |
| ovary | UBERON:0000992 | 70.73 | gold quality |
| left ovary | UBERON:0002119 | 70.36 | gold quality |
| adrenal tissue | UBERON:0018303 | 70.17 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 70.04 | gold quality |
| right adrenal gland | UBERON:0001233 | 69.60 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 69.50 | gold quality |
| bone marrow cell | CL:0002092 | 69.49 | silver quality |
| left adrenal gland | UBERON:0001234 | 69.26 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 69.21 | gold quality |
| prefrontal cortex | UBERON:0000451 | 69.02 | gold quality |
| adrenal gland | UBERON:0002369 | 68.88 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 68.68 | gold quality |
| frontal cortex | UBERON:0001870 | 68.67 | gold quality |
| cerebral cortex | UBERON:0000956 | 68.64 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 68.60 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 68.48 | gold quality |
| right frontal lobe | UBERON:0002810 | 67.54 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.44 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.